Some oncologists are turning to GLP-1 agents to help patients shed excess pounds, with the goal of improving cancer outcomes.

In patients with type 2 diabetes, GLP-1 receptor agonists and SGLT2 inhibitors have similar kidney ... Please see the original reference for a full list of authors’ disclosures.

E arlier this month, Kourtney Kardashian’s supplement brand, Lemme, joined the growing market for Ozempic dupes with the ...

GLP-1R agonist use is associated with a decrease in IOP, although this correlation is not statistically significant.

GLP-1 RAs are being recommended on social media, raising questions about who can see the content and what the effects might ...

The US Food and Drug Administration (FDA) has declared an end to the shortage of tirzepatide, the active ingredient in Eli ...

Tirzepatide, a dual GIP and GLP-1 receptor agonist, has gained widespread recognition for its effectiveness in promoting substantial weight loss by enhancing metabolic functions and controlling ...

Ilant estimates that behavioral therapy can help many people lose up to 5% of their weight, anti-obesity medications can help ...

Kailera Therapeutics has launched into the increasingly crowded obesity space with a portfolio of assets acquired from China ...

PGIM Jennison Health Sciences Fund released its second quarter 2024 investor letter. A copy of the letter can be downloaded ...

If you’ve been trying to reach a healthier weight, you may be considering semaglutide medications like Ozempic and Wegovy.

GLP-1 receptor agonists are being recommended on social media, raising questions about who can see the content and what the ...